Back

The science and trials behind CMIs

10 May 2026 (14:35 - 14:40)
Organised by: Logo
Congress Presentation Part of: Beyond the class effect: exploring distinct mechanisms and clinical profiles of cardiac myosin inhibitors Hypertrophic Cardiomyopathy Open Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Martin Maron

Lahey Hospital & Medical Centre, Burlington (United States of America)

4 More presentations in this session

Presentation thumbnail
Beyond the class effect: exploring distinct mechanisms and clinical profiles of cardiac myosin inhibitors
Doctor M. Maron (Burlington, US)
Presentation thumbnail
Navigating the nuances: comparative CMI profiles
Professor C. Schulze (Jena, DE)
Presentation thumbnail
Rethinking standard of care in obstructive HCM
Doctor M. Michels (Rotterdam, NL)
Presentation thumbnail
Conclusion; EBAC Evaluation
Doctor M. Maron (Burlington, US)

Access the full session

Session thumbnail
Beyond the class effect: exploring distinct mechanisms and clinical profiles of cardiac myosin inhibitors

The Event

Event poster

Heart Failure 2026

10 May 2026 14:35 CET
You may be interested in
thumbnail
Congress Session
Reducing hospitalisations and improving quality of life: why use cardiac contractility modulation (CCM)?
20 May 2023
thumbnail
Congress Presentation
Study design, result reporting and publication of late-stage cardiovascular trials
28 August 2020
thumbnail
Congress Session
Hottest trials and trial updates (2)
18 May 2025
thumbnail
Congress Session
Late-breaking clinical trials in chronic heart failure
18 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources